AAAAAA
Results: 1-25/38
Authors:
Nigon, F
Serfaty-Lacrosniere, C
Beucler, I
Chauvois, D
Neveu, C
Giral, P
Chapman, MJ
Bruckert, E
Citation: F. Nigon et al., Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: Effect of fibrate treatment, CLIN CH L M, 39(7), 2001, pp. 634-640
Authors:
Bastard, JP
Robert, JJ
Jardel, C
Bruckert, E
Grimaldi, A
Hainque, B
Citation: Jp. Bastard et al., Is quantitative insulin sensitivity check index, a fair insulin sensitivity index in humans?, DIABETE MET, 27(1), 2001, pp. 69-70
Authors:
Bruckert, E
Citation: E. Bruckert, The place of phytosterols in treating hyperlipidemic patients, OCL-OL CORP, 8(4), 2001, pp. 312-316
Authors:
Lievre, M
Menard, J
Bruckert, E
Cogneau, J
Delahaye, F
Giral, P
Leitersdorf, E
Luc, G
Masana, L
Moulin, P
Passa, P
Pouchain, D
Siest, G
Citation: M. Lievre et al., Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility, BR MED J, 322(7286), 2001, pp. 603-605
Authors:
Kiortsis, DN
Tzotzas, T
Giral, P
Bruckert, E
Beucler, I
Valsamides, S
Turpin, G
Citation: Dn. Kiortsis et al., Changes in lipoprotein(a) levels and hormonal correlations during a weightreduction program, NUTR MET CA, 11(3), 2001, pp. 153-157
Authors:
Bruckert, E
Giral, P
Turpin, G
Citation: E. Bruckert et al., Hyperlipidemia: new data and new concepts, PRESSE MED, 30(4), 2001, pp. 177-181
The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia.
Authors:
Ducimetiere, P
Signeyrole, D
Giral, P
Hoog-Labouret, N
Amarenco, P
Chanu, B
Chauvenet, M
Coletti, M
Dallongeville, J
Durlach, V
Kawka, G
Krempf, M
Leroux, G
Mlika-Cabanne, N
Monnier, L
Paillard, F
Rostoker, G
Sicard, D
Verny, C
Voiriot, P
Acquart, B
Alquier, G
Ankri, J
Badoc, G
Basdevant, A
Belmin, J
Berthezene, F
Beucler, I
Blanc, F
Broustet, JP
Bruckert, E
Brun, JM
Castaigne, A
Charpentier, JM
Andre, MC
Cogneau, J
Demeaux, JL
Denolle, T
Desson, JF
Drahi, E
Drouin, P
Dumel, F
Emmerich, J
Farnier, M
Fontbonne, A
Forette, B
Gambert, P
Gautier, JC
Guillausseau, PJ
Hommel, M
Janowski, M
Le Goaziou, MF
Lievre, M
Le Quere, M
Leys, D
Marechaud, R
Mas, JL
Menard, J
Michel, JM
Mounier-Vehier, F
Mottier, D
Passa, P
Pinel, JF
Puel, J
Raccah, D
Renou, P
Ribier, A
Schlienger, JL
Thomas, D
Vallee, JP
Veyssier-Belot, C
Bouvenot, G
Abadie, E
Alexandre, JM
Belorgey-Bismut, C
Bergmann, JF
Camelli, B
Caulin, C
Costagliola, D
Denis, C
Dupuis, B
Fleurette, F
Guillevin, L
Hoog-Labouret, N
Paintaud, G
Rauss, A
Poynard, T
Rostoker, G
Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Authors:
Dejager, S
Pichard, C
Giral, P
Bruckert, E
Federspield, MC
Beucler, I
Turpin, G
Citation: S. Dejager et al., Smaller LDL particle size in women with polycystic ovary syndrome comparedto controls, CLIN ENDOCR, 54(4), 2001, pp. 455-462
Authors:
Baril, L
Beucler, I
Valantin, MA
Bruckert, E
Bonnefont-Rousselot, D
Coutellier, A
Caumes, E
Katlama, C
Bricaire, F
Citation: L. Baril et al., Low lipolytic enzyme activity in patients with severe hypertriglyceridemiaon highly active antiretroviral therapy, AIDS, 15(3), 2001, pp. 415-417
Authors:
Chadarevian, R
Bruckert, E
Leenhardt, L
Giral, P
Ankri, A
Turpin, G
Citation: R. Chadarevian et al., Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism, J CLIN END, 86(2), 2001, pp. 732-737
Authors:
Giral, P
Bruckert, E
Jacob, N
Chapman, MJ
Foglietti, MJ
Turpin, G
Citation: P. Giral et al., Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia, ATHEROSCLER, 154(2), 2001, pp. 421-427
Authors:
Beaudeux, JL
Jacob, N
Giral, P
Foglietti, MJ
Bruckert, E
Citation: Jl. Beaudeux et al., New non-lipidic biological markers of atherosclerosis, ANN MED IN, 152(3), 2001, pp. 169-179
Authors:
Girard, S
Bruckert, E
Turpin, G
Citation: S. Girard et al., Endocrine disease in adrenoleukodystrophy, ANN MED IN, 152(1), 2001, pp. 15-26
Authors:
Lu, KM
Lee, MH
Hazard, S
Brooks-Wilson, A
Hidaka, H
Kojima, H
Ose, L
Stalenhoef, AFH
Mietinnen, T
Bjorkhem, I
Bruckert, E
Pandya, A
Brewer, HB
Salen, G
Dean, M
Srivastava, A
Patel, SB
Citation: Km. Lu et al., Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively, AM J HU GEN, 69(2), 2001, pp. 278-290
Authors:
Chapman, JM
Guerin, M
Bruckert, E
Citation: Jm. Chapman et al., Quantitative and qualitative anomalies of LDL: relevance to atherosclerosis, B ACA N MED, 185(1), 2001, pp. 35-39
Authors:
Bruckert, E
Citation: E. Bruckert, Therapeutic and pleiotropic effects of statins for primary and secondary prevention of cardiovascular diseases, B ACA N MED, 185(1), 2001, pp. 49-62
Authors:
Bastard, JP
Jardel, C
Bruckert, E
Vidal, H
Hainque, B
Citation: Jp. Bastard et al., Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity, DIABET OB M, 2(5), 2000, pp. 323-325
Authors:
Bastard, JP
Vidal, H
Jardel, C
Bruckert, E
Robin, D
Vallier, P
Blondy, P
Turpin, G
Forest, C
Hainque, B
Citation: Jp. Bastard et al., Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects, INT J OBES, 24(1), 2000, pp. 70-74
Authors:
Kiortsis, DN
Giral, P
Bruckert, E
Turpin, G
Citation: Dn. Kiortsis et al., Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients, J CLIN PH T, 25(6), 2000, pp. 445-451
Authors:
Bastard, JP
Jardel, C
Bruckert, E
Blondy, P
Capeau, J
Laville, M
Vidal, H
Hainque, B
Citation: Jp. Bastard et al., Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss, J CLIN END, 85(9), 2000, pp. 3338-3342
Authors:
Perez-Mendez, O
Bruckert, E
Franceschini, G
Duhal, N
Lacroix, B
Bonte, JP
Sirtori, C
Fruchart, JC
Turpin, G
Luc, G
Citation: O. Perez-mendez et al., Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris, ATHEROSCLER, 148(2), 2000, pp. 317-326
Authors:
Ratziu, V
Giral, P
Charlotte, F
Bruckert, E
Thibault, V
Theodorou, I
Khalil, L
Turpin, G
Opolon, P
Poynard, T
Citation: V. Ratziu et al., Liver fibrosis in overweight patients, GASTROENTY, 118(6), 2000, pp. 1117
Authors:
Bastard, JP
Hainque, B
Dusserre, E
Bruckert, E
Robin, D
Vallier, P
Perche, S
Robin, P
Turpin, G
Jardel, C
Laville, M
Forest, C
Vidal, H
Citation: Jp. Bastard et al., Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneousadipose tissue in obese women, DIABET M R, 15(2), 1999, pp. 92-98
Authors:
Bruckert, E
Giral, P
Chadarevian, R
Turpin, G
Citation: E. Bruckert et al., Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients, J CARD RISK, 6(5), 1999, pp. 327-331
Authors:
Bruckert, E
Citation: E. Bruckert, Caring for hyperlipidic patients as preventive therapy, OCL-OL CORP, 6(3), 1999, pp. 236-242